Ondine Biomedical’s Capital Raise Fuels Momentum Toward 2027 Product Launch
Ondine Biomedical’s capital raise fuels a strategic push for its photodynamic therapy, Steriwave, positioning the company for commercial launch and potential upside for long‑term investors.
3 minutes to read